Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

National Survey Uncovers the Truth About Cold Sores, Finds Women Go to Great Lengths to Conceal

New Abreva® Conceal™ offers a simple, cover-up solution


News provided by

GlaxoSmithKline Consumer Healthcare

Oct 04, 2012, 08:30 ET

Share this article

Share toX

Share this article

Share toX

PARSIPPANY, N.J., Oct. 4, 2012 /PRNewswire/ -- GlaxoSmithKline Consumer Healthcare today released results from a new national survey of female cold sore sufferers, revealing that cold sores impact many dimensions of a woman's life, including everyday activities, relationships and confidence. Women report feeling self-conscious (86 percent), unattractive (77 percent) and embarrassed (72 percent) with a cold sore. In fact, two-thirds of women say a cold sore feels like the worst thing in the world and that they wouldn't wish it on their worst enemy. GlaxoSmithKline (GSK) recently introduced Abreva® Conceal™, a clear, non-medicated patch that covers cold sores, providing a smooth surface to apply makeup on top.

To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/58304-glaxosmithkline-gsk-abreva-conceal-cold-sore-survey-results-women

(Logo: http://photos.prnewswire.com/prnh/20121004/MM85712LOGO)

"Cold sores are more than just a health or beauty issue; they're a confidence issue," said Carmindy, a professional makeup artist from TLC's TV show What Not to Wear. "I've done makeup for so many different women – from models, to moms, to young professionals, and I've seen how a cold sore can ruin a woman's day and seriously derail her confidence and self-esteem. I've also never had the right product to cover them until now; Abreva® Conceal™ provides a simple solution."

Abreva® Conceal™ uses MicroAir™ technology, which allows air in while keeping contaminants out. Once the cold sore blister has appeared, Abreva® Conceal™ can be placed over it, creating a covered, protected environment for the cold sore for up to eight hours. It can be used with your normal makeup routine – whether that's liquid or powder foundation, lipstick or lip gloss – and provides a smooth surface so that makeup can be applied on top of the patch. Carmindy teamed up with GSK to show consumers how to use the product in a new demonstration video.  

"About 80 million Americans suffer from cold sores in the United States, which can be unsightly and sometimes painful. Our research illustrates the social and emotional impact cold sores can have and the need for products like Abreva® Conceal™," said Dr. Vidhu Bansal, Director of Medical Affairs of GSK Consumer Healthcare. "GSK wanted to provide cold sore sufferers with an option to conceal their cold sores so they don't have to hide from the world. Abreva® Conceal™ helps sufferers face the day with confidence, even with a cold sore."

The Undercover Cold Sore Survey

The Undercover Cold Sore Survey of more than 1,000 women also shows that sufferers go to extreme lengths to cover their cold sores. Nine out of ten respondents noted a cold sore is an ugly surprise and are bothered that there is no way to prepare for one. More than one-third have stayed home because of a cold sore, and one in four women have lied about what a cold sore is. To cover their cold sores, women have even turned to rubbing alcohol, nail polish remover and garlic. Yet 83 percent reported they have never been able to successfully cover up a cold sore, and more than three-quarters (77 percent) reported they are looking for a product specifically designed to cover a cold sore.

Cold sores affect a woman's confidence, including in the work place.

  • Nearly nine out of 10 women (88 percent) don't feel confident with a cold sore, and 83 percent worry about what people are thinking.
  • Approximately three quarters (74 percent) don't like to spend more time in public than absolutely necessary with a cold sore.
  • Approximately 80 percent of respondents also reported feeling less confident or assertive at work or school because of a cold sore, and approximately one-half of respondents avoided people at work or school (53 percent) or social events after work (51 percent).
  • Women feel more self-conscious with a cold sore than food stuck between their teeth, a patch of pimples on their face, or a hickey.

Relationships and intimacy suffer as a result of cold sores and can even impact the biggest day of a woman's life, her wedding day.

  • Seventy-one percent avoided being intimate with their partner. In fact, nearly two-thirds (65 percent) would rather not kiss their boyfriend for a month than have a cold sore on a first date (35 percent).
  • In turn, approximately one in three (34 percent) sufferers said their partner avoided being intimate with them.
  • Nearly one-quarter (23 percent) of respondents also reported they cancelled or rescheduled a date because of a cold sore.
  • The majority (63 percent) also reported that they couldn't imagine having anything worse than a cold sore on their wedding day. In fact, 9 in 10 women (91 percent) would have a photo edited to remove the cold sore.
  • A majority of brides were nervous about getting a cold sore on their wedding day. In fact, brides reported that they were more nervous about a cold sore (61 percent) than looking heavier (47 percent) or not having hair (48 percent) or makeup (36 percent) look the way they wanted.

Abreva® Conceal™ is available to retailers nationwide. For more information about Abreva® Conceal™, please visit www.Abreva.com and to see Carmindy's demonstration video, visit http://youtu.be/nSZkFeaI57c.   

About Cold Sores

A cold sore is a blister that forms on or around the lips and is usually caused by the Herpes Simplex Virus (HSV-1). HSV-1 usually affects the lips or mouth, but can spread to the eyes or genitals. Most cold sore sufferers aren't exactly sure when they first encountered the virus because HSV-1 is usually contracted early in childhood.  While it's likely that 90 percent of adults have been infected by the cold sore virus, not everyone gets cold sore outbreaks.  Actually, only 20 percent to 40 percent of people will experience cold sores.

About the Survey

The survey was designed the gather insights on the emotional and social impact of cold sores. The survey reveals the impact of cold sores has many dimensions of a person's life including everyday activities, relationships and confidence. The survey demonstrates there is a significant unmet need for a product like Abreva® Conceal™ to help women cover and protect their cold sore while it heals. Abreva® Conceal™ covers your cold sore in an instant, and allows the "real you" to shine through and face the day with confidence.

Research for the cold sore sufferer survey was conducted and fielded by Edelman Berland: 1,022 adult female cold sore sufferers, who experience two or more cold sores annually, were questioned. The survey was fielded online between August 23 and August 31, 2012 and consisted of 30 questions.

About Abreva

Abreva is the only FDA-approved over-the-counter product to speed the healing of cold sores. Abreva contains 10 percent docosanol.   

About GlaxoSmithKline Consumer Healthcare

GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its well-known brands include Nicorette® and NicoDerm® CQ, the leading smoking cessation products; alli, the only FDA-OTC weight loss aid; as well as medicine cabinet staples, Aquafresh®, Sensodyne®, Tums® and Breathe Right®, all of which are trademarks owned by and/or licensed to GlaxoSmithKline Group of Companies.

About GlaxoSmithKline®

GlaxoSmithKline – one of the world's leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit: GSK.com.

Carmindy is a paid spokesperson for Abreva® Conceal™ but her opinions are her own.   

 

Media Relations:

GSK Consumer Healthcare

 Deborah Bolding



[email protected]

(973) 889-2344

 

Edelman

Catherine McCormack



[email protected]

(212) 819-4816

SOURCE GlaxoSmithKline Consumer Healthcare

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.